Levilimab

(Synonyms: BCD-089)
Customer Review

Based on 1 Customer Validation

Levilimab (BCD-089) is an IL-6 receptor blocker that binds to both membrane-bound and soluble IL-6Rα. Levilimab inhibits IL-6 signaling, including classical signaling and trans-signaling, by blocking IL-6 binding. Levilimab can be used in research on rheumatoid arthritis and COVID-19.

For research use only. We do not sell to patients.

  • Purity : 97.52%
  • CAS No.: 2035008-70-7
  • Molecular Weight:145.7 kDa
  • Storage:
    Shipping with dry ice

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Protocols
  • Purity & Documentation
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00